This study evaluated the in-vitro anticancer activity of different thiosemicarbazones (HacTSc, HSTsc, against MCF-7 human breast cancer cell line and MCF-10 normal cell. Materials and Methods: The ligands were prepared and characterized by UV vis, IR, 1 H NMR. MTT assay was used to determine cell viability. Then data were analyzed using two-way ANOVA with Tukey post-hoc test. Result: The ligands have IC50 value ranging from 2.271µg/ml to 7.081µg/ml. Acetone thiosemicarbazone and 3-Methoxybenzaldehyde thiosemicarbazone, were identified as the most potent against MCF-7 breast cancer cells with IC50 value of 2.271µg/ml and 2.743µg/ml respectively. Whereas 4-Nitrobenzaldehyde thiosemicarbazone was the least potent. Also, the IC50 of the normal MCF-10 cell indicated their activity were selective. Conclusion: The activity of the ligands were dose, position and substituents dependent. Acetone thiosemicarbazone and 3-Methoxybenzaldehyde thiosemicarbazone are promising anticancer agents for further study.
Introduction
Thiosemicarbazones (hydrazine carbothioamides) are a family of compounds with high biological activity (1). Due to their versatile biological and pharmacological activities, their derivatives are of particular importance. They are good intermediates for pharmaceutical and bio-active material synthesis and are therefore, commonly used in medicinal chemistry field. They have also found their way into all branches of chemistry; they are used commercially as dyes, photographic films, plastic and textiles (2). In the past years, thiosemicarbazone derivatives have shown a wide range of biological activity viz. antifungal (3, 4), anti-tumor/cancer (5-10), Antimicrobial (11-13), sodium channel blocker (14) , antiviral (15, 16) .
Cancer is a malignant and invasive growth or tumor, especially of epithelium origin, which tends to recur after excision and may metastasize to other sites. It occurs due to failure of the mechanism that usually controls the growth and proliferation of cells (17) . Cancer may affect people of all ages, and with increase in age the exposure to most type of cancer increases. Similarly, it can affect all parts of the body, for instance, lung and breast cancers are common all over the world (18) .
Breast cancer is the most common type of cancer and the second leading cause of death among women worldwide (19) . It affects 2.1 million women each year, and in 2018, an estimated 627,000 women died from breast cancerabout 15% of all female cancer deaths. While the rates of breast cancer among women are higher in developed region, rates are increasing globally in almost in every country (20) .
Studies have shown that multi-drug resistance and unwanted side effects of current cancer chemotherapeutic contribute to an increased interest towards the development of new anticancer cancer drug, including synthetic compounds with minimal toxicity to normal tissue and highly effective with lower tumor cell resistance (21, 22) . The present work is designed to evaluate the cytotoxic effects of different thiosemicarbazones on MCF-7 human breast cancer cell line.
Material and Methods
All chemicals used were commercial products of analytical reagent grade procured from Sigma-Aldrich, except for the ligands, which were prepared by the reaction of MeOH and water solutions with different substituent and thiosemicarbazide using the procedures depicted below.
Synthesis of Acetone Thiosemicarbazone (HacTsc): Acetone thiosemicarbazone
(C4H9N3S) was prepared by refluxing and stirring a mixture of acetone (0.02mmol, 1.16g) and thiosemicarbazide (0.02mmol, 1.822g) in 20ml distilled water. The mixture was refluxed for 15 min (40 o c) and stirred for while resulting yellow colored solution, which was kept undisturbed. Then, a crystalline white product was separated out. Yield, 2.68g, Insoluble in: CHCl3, CCl4, H2O; soluble in DMSO, DHF/THF, CH3CN, ethanol, Methanol
Figure 1 Preparation of Acetone thiosemicarbazone

Synthesis of Salicylaldehyde Thiosemicarbazone (HSTsc):
Salicylaldehyde thiosemicarbazone, C8H9N3OS, was prepared by refluxing the mixture of salicylaldehyde (2.4 ml, 0.01mmol) and thiosemicarbazide (2.0g, 0.01 mmol) in a mixture of methanol (30 ml) and distilled water(30ml) as the solvent medium in the presence of glacial acetic acid (2-3 ml). The reaction mixture was refluxed for about 3-4 hours, resulting in a yellow colored solution, which was kept undisturbed. The next day, a crystalline yellow product was separated out. Yield Physical measurements: The structure of the ligand was confirmed from UV-Vis, infrared and 1 H NMR spectral studies. UV Vis Spectroscopy was done by taking DMSO as reference sample or blank. The infrared spectroscopy was conducted to check whether the ligand is properly prepared or not. Also, 1 H, nuclear magnetic resonance (NMR) spectra was measured in dimethyl sulfoxide (DMSO)-d6 as internal reference at ambient temperature. Also, the physical properties of the compounds were checked.
Cell lines and cell culture:
The test compound was studied for short-term in vitro anticancer activity against MCF-7 breast cancer cell line and for comparison, MCF-10 normal cell line was used. The cell lines were initially procured from the National Centre for Cell Science, Pune (NCCS). Cells were cultured in a 6 walled culture plate using Dulbecco's Modified Eagle's Medium, that was supplemented with 10% fetal bovine serum at 95% air condition with 5% of carbon dioxide (CO2) in 37°C Temperature.
MTT cell viability assay Cell count:
Before the cell viability test conducted cells were counted using hemocytometer (x10 4 cell/ml). Then cell viability was assessed by MTT assay using ATCC MTT Cell Proliferation Assay kit. MCF-7 and MCF-10 cell lines were plated separately in 96 well plates at a concentration of 1 x 10 4 cells/well. After 48 hr. the media was removed and cells were washed twice with 100μl serum-free medium. Then 10μl MTT Reagent was added and left for incubation for 4 h at 37 o C in a CO2 incubator, until intracellular purple formazan crystals are visible (until purple precipitate is visible).
After that, MTT containing medium was discarded, the cells were washed with PBS (200μl). The crystals were then dissolved by adding 100μl of DMSO and mixed properly by pipetting up and down and left at room temperature in the dark for 2 hours. Spectro photometrical absorbance of the purple blue formazan dye was measured in a microplate reader at 570 nm. Then, percent Cell viability was calculated using the following formula.
% Cell viability = 100
Evaluation of anticancer potential: 
Results
The synthesis of different thiosemicarbazones were carried out according to the steps depicted in materials and methods section. The structures of the ligands were confirmed from UV-Vis, infrared and 1 H NMR spectral studies.
Anticancer activity of different thiosemicarbazone on MCF-7 breast cancer cell:
MTT assay was used to test the anticancer activity of different substituent of thiosemicarbazone on MCF-7 breast cancer and MCF-10 normal cells. The half inhibitory concentration (IC50) of the test compounds was calculated using GraphPad prism software and presented in table1. According to the IC50 value, Acetone thiosemicarbazone by having IC50 value of 2.271 µg/ml is found to be the most potent and 4-Nitro benzaldehyde with IC50 value of 7.081 µg/ml is found to be the least potent. On the other hand, 3-methoxybenzaldehyde TSc (IC50=2.743 µg/ml) showed a comparable activity with Acetone thiosemicarbazone. On the other hand, the IC50 values of those ligands used in MCF-10 were higher than that of MCF-7 except in 4-nitro benzaldehyde
where it is lower (2.255 µg/ml).
Acetone thiosemicarbazone inhibit the growth MCF-7 breast cancer cell line in lower concentration:
The growth inhibition effect of HacTSc on MCF-7 and MCF-10 cells treated with different concentration was tested using MTT assay. The result (table 2 and figure 6A ) suggested that, HaTSc inhibit approximately 6% percent of the tumor cell at concentration of 5 µg/ml and decrease to 3.5 % cell as the concentration increased to 20 µg/ml. The ligand's toxicity to the normal cell showed cell viability increased as the concentration increase. This result suggests that Acetone thiosemicarbazone might be effective if it is used in very minimal concentration than high concentration.
Salicylaldehyde thiosemicarbazone inhibit the growth MCF-7 breast cancer cell line:
The MTT assay result showed that HSTSc has highly significant (p<0.001) growth inhibition on MFC-7 and MCF-10 cell. As depicted in table 3 and figure 6B , the test ligand showed 19% to 25% growth inhibition of MCF-7 when the concentration increased from 5 µg/ml to 20 µg/ml. On the other hand, MCF-10 growth inhibition suggest that the compound is less toxic to the normal cell with 97.6 % and 96.8% of viable cell after treatment of 5 µg/ml and 20 µg/ml respectively.
Effect of 3-Methoxy benzaldehyde thiosemicarbazone on cell viability: As presented
in table 4 and figure 6C , 3-MBTSc showed a very promising and a significant (p<0.001) growth inhibition activity. It inhibits almost 33% of tumor cell growth at 5 µg/ml and continue up to 36.5% at 20 µg/ml. Comparing its toxicity to the normal cell at the same concentration the ligand inhibits 7-8% of MCF-10 cell growth.
The effect of 4-Nitro benzaldehyde thiosemicarbazone on cell viability:
As demonstrated in table 5 and figure 6D, 4-NBTSc inhibits around 13% of cells growth and continue up to 40% with increase in concentration from 5 µg/ml to 20 µg/ml. Also, the test ligand showed constant inhibition increment with small change in treatment concentration;
at 10 µg/ml its effect was 25% and it increase by 9% and inhibit 34% of the cells while the dose is only 12 µg/ml. However, the ligand showed slight toxicity to normal cells and it inhibit 12-16 % MCF-10 cell growth. This output suggested that the activity of this ligand is promising but it might not be selective.
The effect of 4-hydroxy benzaldehyde thiosemicarbazone on cell viability:
According to the MTT assay result (table 6 and figure 6E ), 4-HBTSc showed a very promising and highly significant (p<0.001) growth inhibition effect on MFC-7 and MCF-10 cells. It showed a 49.27% growth inhibition at dose of 20 µg/ml. Surprisingly at the concentration of 5 µg/ml it inhibits 38% of MCF-7 cells growth while it only inhibits 3% of MCF-10 normal cell. This result indicted that the compound is very promising for further study.
Discussion
It was reported that structural variation, type substituent, cancer types and dose can affect the function of the compound (23) (24) (25) (26) . The IC50 and the ANOVA result in the current study also confirmed that, the activities of the ligands were significantly varied due to substituent type, dose and the type of cell line. As indicated in table 1, Acetone thiosemicarbazone with the IC50 value of 2.271 µg/ml is found to be the most potent and 4-Nitro benzaldehyde with IC50 value of 7.081 µg/ml is found to be the least potent. Acetone, which is the simplest and the smallest Ketone as a substituent showed a better anticancer activity than all aldehyde substituents used for this study. This could be correlated with the location of the substituent, as acetone is positioned with non-aromatic nature, while the other ligand substituents are located in the different position of the benzene ring.
Conversely, among the benzene ring substituents we synthesized the methoxy group in 3-methoxy benzaldehyde thiosemicarbazone showed a better activity than the Nitro and hydroxy substituent. In fact, when we see the activity of the hydroxy group on its own, the effect of the substituent position is found to be lower.
Similarly, MCF-10 normal cell line was used to determine whether the test compounds were toxic or nontoxic to healthy cells. The IC50 values of those ligands used in MCF-10 were higher than that of MCF-7 except in 4-nitro benzaldehyde where it is lower. These results generally indicated that most of the ligands are selective in their anticancer effect.
Particularly Acetone thiosemicarbazone showed highly selective activity with an IC50 value of 115.8 µg/ml against the normal cell line. On the contrary, 4-nitro benzaldehyde showed highly toxic activity with IC50 value of 2.255 µg/ml to the normal cell line.
The cell viability result revealed that the inhibition of cell growth significantly increased with an increase in dose and varies with a substituent except for Acetone thiosemicarbazone where the inhibition has decreased as the dose increases ( and 10 µg/ml respectively. The other ligands also showed a mild and comparable effect.
In line with this, with an increase in dose, 4-NBTSc and 3-MBTSc showed 40% and 35 % of growth inhibition respectively (table 4 and 5). On the contrary, the lowest growth inhibition effect was observed at doses of 20 µg/ml (table 2) 
